HSBC Holdings’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.4K Buy
+18,704
New +$63.5K ﹤0.01% 2810
2025
Q3
Sell
-39,213
Closed -$110K 2765
2025
Q2
$110K Buy
+39,213
New +$129K ﹤0.01% 2832
2023
Q2
Sell
-46,050
Closed -$39.1K 2583
2023
Q1
$39.1K Sell
46,050
-9,838
-18% -$10.8K ﹤0.01% 2580
2022
Q4
$50.8K Hold
55,888
﹤0.01% 2967
2022
Q3
$96K Sell
55,888
-8,754
-14% -$22.9K ﹤0.01% 2750
2022
Q2
$138K Buy
64,642
+38,477
+147% +$102K ﹤0.01% 2971
2022
Q1
$92K Buy
26,165
+35
+0.1% +$101 ﹤0.01% 3136
2021
Q4
$98K Buy
26,130
+15,800
+153% +$96.9K ﹤0.01% 3141
2021
Q3
$76K Sell
10,330
-1,470
-12% -$12.6K ﹤0.01% 2908
2021
Q2
$161K Buy
+11,800
New +$116K ﹤0.01% 2794

Other funds holding CLOV

HSBC Holdings's CLOV Position: Q2 2026 in Review

HSBC Holdings opened a new position in Clover Health Investments (CLOV) in Q2 2026: 18,704 shares worth $98.4K. The stake represents ﹤0.01% of the portfolio and ranks #2810 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CLOV as recently as Q2 2025.

HSBC Holdings first reported a position in CLOV in Q2 2021 and has held it in 10 quarters since. The position peaked at $161K in Q2 2021. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • HSBC Holdings held 18,704 shares of Clover Health Investments worth $98.4K as of Q2 2026.
  • Clover Health Investments was a new HSBC Holdings position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2810 holding.
  • HSBC Holdings first reported a position in Clover Health Investments in Q2 2021 and has held it in 10 quarters since.
  • HSBC Holdings's Clover Health Investments position peaked at $161K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.